论文信息 - Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer - 字舞流文

Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer

A. Chakravarti | T. Williams | J. Trevino | Z. Cruz-Monserrate | Linlin Yang | Adam R Wolfe | R. Robb | A. Hegazi | L. Abushahin | D. Shyu | John R. Jacob | K. Palanichamy